X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    DARZALEX FASPRO

    FDA Approves J&J’s DARZALEX FASPRO for HR-SMM in Adults

    thymidine kinase 2 deficiency

    FDA Approves UCB’s KYGEVVI for Thymidine Kinase 2 Deficiency

    supercomputer for drug research

    Lilly, NVIDIA Partner on AI Supercomputer for Drug Research

    biosimilar development

    FDA Unveils Initiative for Faster Biosimilar Development

    Novartis ianalumab Sjogrens trial

    Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials

    EU Approval for Koselugo

    AstraZeneca Secures EU Approval for Koselugo to Treat NF1 PN

    Cancer Research

    Guardant Health, Zephyr AI Collab to Advance Cancer Research

    CDMO market growth trends

    Biobeat Report: CDMO Growth in China and USA for 2026

    Ulcerative Colitis

    FDA Approves Omvoh by Eli Lilly for Ulcerative Colitis

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    DARZALEX FASPRO

    FDA Approves J&J’s DARZALEX FASPRO for HR-SMM in Adults

    thymidine kinase 2 deficiency

    FDA Approves UCB’s KYGEVVI for Thymidine Kinase 2 Deficiency

    supercomputer for drug research

    Lilly, NVIDIA Partner on AI Supercomputer for Drug Research

    biosimilar development

    FDA Unveils Initiative for Faster Biosimilar Development

    Novartis ianalumab Sjogrens trial

    Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials

    EU Approval for Koselugo

    AstraZeneca Secures EU Approval for Koselugo to Treat NF1 PN

    Cancer Research

    Guardant Health, Zephyr AI Collab to Advance Cancer Research

    CDMO market growth trends

    Biobeat Report: CDMO Growth in China and USA for 2026

    Ulcerative Colitis

    FDA Approves Omvoh by Eli Lilly for Ulcerative Colitis

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Health & Nutrition

Royal DSM Completes Acquisition of Specialty Dairy Solutions Provider CSK

Content Team by Content Team
7th January 2020
in Health & Nutrition, News
Royal DSM Completes Acquisition of Specialty Dairy Solutions Provider CSK

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The collaboration between Royal DSM and CSK will enable DSM to cater to the growing dairy markets around the globe. The deal was closed for a cash consideration of about 167 million dollars.

Heerlen/The Netherlands – Royal DSM, a global science-based company in nutrition, health and sustainable living, has recently announced the completion of the acquisition of a 100 % interest in specialty dairy solutions provider Koninklijke CSK Food Enrichment (CSK) for a cash consideration of about 167 million dollars. The acquisition of CSK was first announced on November 18.

The highly complementary combination of DSM’s dairy business and CSK’s business greatly strengthens DSM’s ability to serve the needs of dairy industries worldwide, and makes the company well-placed to address the fast-growing and attractive dairy cultures markets.

Previous Post

Cergentis launches TLA technology for complete cancer gene mutation sequencing

Next Post

Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

Related Posts

DARZALEX FASPRO
Americas

FDA Approves J&J’s DARZALEX FASPRO for HR-SMM in Adults

8th November 2025
thymidine kinase 2 deficiency
Americas

FDA Approves UCB’s KYGEVVI for Thymidine Kinase 2 Deficiency

7th November 2025
Manufacturing Facility
Americas

Lilly to Expand its Manufacturing Facility in Puerto Rico

6th November 2025
manufacturing facility
Europe

Lilly to Build $3B Manufacturing Facility in Netherlands

6th November 2025
supercomputer for drug research
Americas

Lilly, NVIDIA Partner on AI Supercomputer for Drug Research

5th November 2025
biosimilar development
Drug Development

FDA Unveils Initiative for Faster Biosimilar Development

5th November 2025
Next Post
Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive
  • Newsletter Subscription

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In